EP 1235576 A2 20020904 - COMBINATIONS OF SUMATRIPTAN OR NARATRIPTAN WITH CYCLOOXYGENASE II INHIBITOR
Title (en)
COMBINATIONS OF SUMATRIPTAN OR NARATRIPTAN WITH CYCLOOXYGENASE II INHIBITOR
Title (de)
KOMBINATIONEN VON SUMATRIPTAN ODER NARATRIPTAN MIT CYCLOOXYGENASE II HEMMER
Title (fr)
COMBINAISONS DE SUMATRIPTAN OU DE NARATRIPTAN AVEC L'INHIBITEUR DE CYCLOOXYGENASE II
Publication
Application
Priority
- GB 0004532 W 20001128
- GB 9929039 A 19991208
Abstract (en)
[origin: WO0141749A2] A method of treating conditions associated with cephalic pain and alleviating the symptoms associated therewith which comprises administering to a mammal, including man, a 5HT1 agonist or a physiologically acceptable salt or solvate thereof and 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo[1,5-b]pyridazine or a physiologically acceptable salt or solvate thereof.
IPC 1-7
IPC 8 full level
A61K 31/4045 (2006.01); A61K 31/50 (2006.01); A61K 31/501 (2006.01); A61K 31/5025 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 25/00 (2006.01); A61P 25/04 (2006.01); A61P 25/06 (2006.01)
CPC (source: EP)
A61K 31/4045 (2013.01); A61K 31/50 (2013.01); A61K 31/501 (2013.01); A61K 45/06 (2013.01); A61P 25/00 (2017.12); A61P 25/04 (2017.12); A61P 25/06 (2017.12)
Citation (search report)
See references of WO 0141749A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0141749 A2 20010614; WO 0141749 A3 20020321; AU 1715901 A 20010618; EP 1235576 A2 20020904; EP 1522305 A1 20050413; GB 9929039 D0 20000202; JP 2003516349 A 20030513
DOCDB simple family (application)
GB 0004532 W 20001128; AU 1715901 A 20001128; EP 00979767 A 20001128; EP 05075041 A 20001128; GB 9929039 A 19991208; JP 2001543094 A 20001128